ArticleJournal of cellular and molecular medicine2019

NF-κB/NKILA signaling modulates the anti-cancerous effects of EZH2 inhibition.

Suzann Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.